postoperative aspiration pneumonia among adults using glp-1 receptor agonists PDF) Impact of GLP-1 Receptor Agonists

Description

GLP-1 drugs such as semaglutide are reshaping treatment of obesity, diabetes and cardiovascular disease with broader physiological effects now emerging.

Henney 2024) demonstrated a potentially meaningful reduction in incident pneumonia with GLP-1 RAs compared with dipeptidyl peptidase-4 (DPP-4) inhibitors (hazard ratio [HR] 0.60, 95% confidence interval [CI] 0.580.62

For professionals in pharma, clinical research, and regulatory affairs, this space is evolving fastand full of opportunity

Turn ordinary foods into functional superfoods with GLP-1 Daily Support, a 4-in-1 prebiotic blend that naturally aids appetite control, blood sugar balance, and metabolic health

Tirzepatide is a promising drug withdual-acting glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) receptor activation that has revolutionized the treatment of type 2 diabetesmellitus (T2DM) as an adjunct to ...